Small Molecule CMO/CDMO Market to Reach $114.17 Bn by 2032

The global small molecule CMO/CDMO market is forecasted to grow from $79.28 billion in 2025 to $114.17 billion by 2032, reflecting a CAGR of 5.3%. This expansion is driven by increasing outsourcing of pharmaceutical manufacturing, rising drug development activities, and growing demand for cost-effective production solutions.